358
Participants
Start Date
May 11, 2023
Primary Completion Date
February 28, 2027
Study Completion Date
February 28, 2027
XTX301
XTX301 monotherapy
RECRUITING
University of Pittsburgh Medical Center-Hillman Cancer Center, Pittsburgh
RECRUITING
The Ohio State University Wexner Medical Center, Columbus
RECRUITING
University Hospital Cleveland Medical Center, Cleveland
RECRUITING
The Gabrail Pharmacology Phase 1 Research Center, Canton
RECRUITING
Medical College of Wisconsin, Milwaukee
RECRUITING
HealthPartners Frauenshuh Cancer center, Saint Louis Park
RECRUITING
Washington University School of Medicine, St Louis
RECRUITING
Tranquil Clinical Research, Webster
RECRUITING
University of California, Davis Comprehensive Cancer Center, Sacramento
RECRUITING
Yale Cancer Center, New Haven
RECRUITING
Hackensack University Medical Center, Hackensack
Xilio Development, Inc.
INDUSTRY